Grail (NASDAQ:GRAL) Sees Strong Trading Volume – What’s Next?

Grail, Inc. (NASDAQ:GRAL) saw unusually-strong trading volume on Tuesday . Approximately 945,734 shares changed hands during trading, a decline of 26% from the previous session’s volume of 1,280,710 shares.The stock last traded at $61.89 and had previously closed at $55.02.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on GRAL shares. Wolfe Research started coverage on Grail in a research report on Friday, November 15th. They set a “peer perform” rating on the stock. Morgan Stanley started coverage on Grail in a research report on Wednesday, November 27th. They set an “equal weight” rating and a $16.00 target price on the stock.

Grail Price Performance

The stock has a 50-day moving average of $24.61 and a 200-day moving average of $18.40.

Institutional Investors Weigh In On Grail

Institutional investors and hedge funds have recently made changes to their positions in the business. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors purchased a new stake in shares of Grail in the fourth quarter worth $244,000. Moloney Securities Asset Management LLC purchased a new stake in shares of Grail in the fourth quarter worth $559,000. Wesbanco Bank Inc. purchased a new stake in shares of Grail in the fourth quarter worth $523,000. Slow Capital Inc. purchased a new stake in shares of Grail in the fourth quarter worth $2,379,000. Finally, abrdn plc purchased a new stake in shares of Grail in the fourth quarter worth $3,768,000.

Grail Company Profile

GRAIL, Inc is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA.